GENERIC & MODE OF SIDE EFFECT/ NURSING

BRAND NAME CLASSIFICATION ACTION INDICATION CONTRAINDICATION ADVERSE RESPONSIBILITIES

EFFECT
Relaxes  Bronchospasm  Contraindicated CNS:  Give subcutaneous
Bronchodilators bronchial in patients with in patients nervousness, injections in the
TERBUTALIN smooth reversible hypertensive to drug tremor, side of the deltoid.
muscle by obstructive or symphatomimetic Drowsiness,  Protect drug from
E SULFATE beta2 agonist stimulating airway disease amines. dizziness,wea light.
Brethine beta2 kness. Don’t use if
Pregnancy risk receptors Adults and  Use cautiously discolored.
AVAILABLE FORMS category B children age 12 in pt. CV:  Drug may reduce
Injection: 1mg/ml and older: with CV disorders, Palpitations, the sensitivity of
Tablets: 2.5mg, Route: P.O 0.25mg hyperthyroidism, Arrhythmia spirometry for the
5mg Onset: 30 subcutaneously. diabetes,or , diagnosis of
min Repeat in 15 to seizure disorders tachycardia,fl bronchospasm.
Peak: 2-3hr 30 minutes, ushing  Look alike-sound
Duration: p.r.n. alike: Don’t
4-8hr Maximum,0.5m G.I: confuse
g in 4 hours Vomiting,nau terbutaline with
sea, tolbutamide or
Route: Adults and Heartburn terbinafine.
SubQ adolescents
Onset: 15 older than age Metabolic: PATIENT TEACHING:
min 15: Hypokalemia  Make sure patient
Peak: Give 2.5 to 5 mg and caregivers
30min P.O t.i.d q6hrs Respiratory: understand why
Duration: while awake. Paradoxical patient needs
1/12 to 4 Maximum,15mg bronchospas drug.
hr daily. m with
prolonged  Remind patient to
Children ages use,dyspnea. separate oral
12 to 15: doses by 6 hours.
Give 2.5mg P.O Skin:
t.i.d q6hrs while Diaphoresis.
awake.
Maximum, 7.5
mg daily
 GENERIC & MODE OF SIDE EFFECT/ NURSING
BRAND NAME CLASSIFICATION ACTION INDICATION CONTRAINDICATION ADVERSE RESPONSIBILITIES
EFFECT
 motor  To prevent and  Contraindicated CNS:  Monitor and
activity of treat in pregnant seizures,strok record BP,PR, and
METHYLER- Oxytocics the uterus postpartum patients, in e with I.V uterine
by direct hemorrhage patients use,dizziness, response;report
GONOVINE Ergot alkaloid stimulation caused by sensitive to headache,hal sudden change in
MALEATE of the uterine atony or ergot lucinations. vital signs,frequent
Methergine Preganancy risk smooth subinvolution preparations, periods of uterine
category C muscle, and in patients CV: relaxation,charact
shortening Adults: 0.2mg with HPN or HPN,transien er and amount of
AVAILABLE t chest
the third I.M q2-4hrs to a toxemia. vaginal bleeding.
FORMS:
stage of max. of 5 doses.  Use cautiously pain,palpitati  Monitor
Injection:0.2mg/ml ons,hypotens
labor, and For excessive in patients with contractions,which
in 1-ml ampoules ion,thrombo-
reducing uterine bleeding sepsis, may begin
Tablets:0.2mg phlebitis.
blood loss. or other obliterate immediately.
Route: P.O emergencies,0.2 vascular Contractions may
Onset:5- mg I.V over 1 disease, or EENT: continue for up to
10min minute while hepatic or renal Tinnitus,nasal 45mins after I.V
Peak: monitoring disease. congestion. use or for 3hrs or
30min blood pressure  Use cautiously more after P.O or
Duration: and uterine during last stage GI: I.M use.
3hr contractions. of labor. nausea,vomi  Store tablets in
Route:I.V After first I.M or ting,diarrhea, tightly closed,light-
Onset:imm I.V dose,0.2mg foul taste. resistant
ediate P.O q6-8hrs for container. Discard
Peak: 2-7days. GU: if discolored.
Unknown  dosage if Hematuria  Look alike-sound
Duration: severe cramping alike:Don’t confuse
45min occurs. Musculo- Methergine with
Route:I.M skeletal: terbutaline
Onset:2- leg cramps PATIENT TEACHING:
5min Respiratory:  Explain use of drug
Peak: Dyspnea to pt. and family
Unknown Skin:  Instruct pt. to
Duration: diaphoresis report adverse
3hr reactions
 promptly.

GENERIC & MODE OF SIDE EFFECT/ NURSING

BRAND NAME CLASSIFICATION ACTION INDICATION CONTRAINDICATION ADVERSE RESPONSIBILITIES
EFFECT